249 related articles for article (PubMed ID: 20083343)
1. BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study.
Wu Y; McEwen GD; Harihar S; Baker SM; DeWald DB; Zhou A
Cancer Lett; 2010 Jul; 293(1):82-91. PubMed ID: 20083343
[TBL] [Abstract][Full Text] [Related]
2. Subcellular spectroscopic markers, topography and nanomechanics of human lung cancer and breast cancer cells examined by combined confocal Raman microspectroscopy and atomic force microscopy.
McEwen GD; Wu Y; Tang M; Qi X; Xiao Z; Baker SM; Yu T; Gilbertson TA; DeWald DB; Zhou A
Analyst; 2013 Feb; 138(3):787-97. PubMed ID: 23187307
[TBL] [Abstract][Full Text] [Related]
3. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.
DeWald DB; Torabinejad J; Samant RS; Johnston D; Erin N; Shope JC; Xie Y; Welch DR
Cancer Res; 2005 Feb; 65(3):713-7. PubMed ID: 15705865
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
5. AFM indentation study of breast cancer cells.
Li QS; Lee GY; Ong CN; Lim CT
Biochem Biophys Res Commun; 2008 Oct; 374(4):609-13. PubMed ID: 18656442
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo].
Jiang J; Xia M; Feng JB; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):398-402. PubMed ID: 17697602
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterisation of the breast cancer metastasis suppressor, BRMS1.
Smith J; Naseem R; Webb M
Protein Expr Purif; 2009 Oct; 67(2):70-5. PubMed ID: 19401233
[TBL] [Abstract][Full Text] [Related]
8. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
9. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
Samant RS; Debies MT; Hurst DR; Moore BP; Shevde LA; Welch DR
Cancer Lett; 2006 Apr; 235(2):260-5. PubMed ID: 15978719
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
11. AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells.
Dorfleutner A; Stehlik C; Zhang J; Gallick GE; Flynn DC
J Cell Physiol; 2007 Dec; 213(3):740-9. PubMed ID: 17520695
[TBL] [Abstract][Full Text] [Related]
12. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13.
Seraj MJ; Samant RS; Verderame MF; Welch DR
Cancer Res; 2000 Jun; 60(11):2764-9. PubMed ID: 10850410
[TBL] [Abstract][Full Text] [Related]
13. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
14. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].
Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068
[TBL] [Abstract][Full Text] [Related]
15. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
17. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
19. Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.
Cai W; Ye L; Sun J; Mansel RE; Jiang WG
Int J Mol Med; 2010 Apr; 25(4):573-80. PubMed ID: 20198306
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
